an independent news feed from Current Medicine Group™
- Latest oncology research
- Clinical trials
- Healthcare initiatives
- Practice guidelines
-
- Jul 5, 2010
- Heterocyclic amines not linked to prostate cancer across ethnicities Despite hypothesizing to the contrary, researchers have found no significant association between the heterocyclic aromatic amines found in well-done meat and an increased risk for prostate cancer.
-
- Jul 2, 2010
- Prostate cancer screening reduces mortality over long time period The results of a 14-year Swedish study show that being invited to screening for prostate cancer reduces prostate cancer-specific mortality rates by nearly 50%.
-
- Jul 1, 2010
- High BMI linked to low prostate cancer detection in Asian men Study results from the Republic of Korea show that having a high body mass index is significantly associated with a decreased risk for the detection of prostate cancer using a contemporary 12-core biopsy method.
-
- Jul 1, 2010
- Statin users may be less likely to experience prostate cancer recurrence Prostate cancer patients treated with radical prostatectomy may be less likely to experience disease recurrence after surgery if they use certain cholesterol-lowering drugs, report US researchers.
-
- Jun 30, 2010
- Prostate enlargement in obesity may confound hemodilution of PSA levels The threshold of prostate-specific antigen for prostate cancer screening should not be lowered based on hemodilution in obese men, as body mass index-related prostate enlargement can raise levels, say South Korean researchers.
-
- Jun 29, 2010
- Prostate EBRT increases risk for severe genitourinary toxicity Men treated for prostate cancer with external beam radiotherapy after transurethral resection of the prostate have a higher risk for severe genitourinary toxicity than those who have not undergone the procedure, conclude US researchers.
-
- Jun 29, 2010
- CVD risk increased with endocrine therapy in prostate cancer patients Prostate cancer patients have an increased risk for nonfatal and fatal cardiovascular disease, particularly those receiving endocrine treatment, researchers have discovered.
-
- Jun 28, 2010
- Laxative/antiflatulent diet does not reduce intrafraction prostate motion For prostate cancer patients voiding their rectum before imaging, an antiflatulent diet and milk of magnesia laxative does not significantly reduce initial rectal area or intrafraction prostate motion, show Canadian study results.
-
- Jun 25, 2010
- After prostate treatment, physicians mostly agree with patients on adverse events In a study of men treated with external beam radiotherapy and total androgen blockade for prostate cancer, the pelvis-related adverse events recorded by physicians were in acceptable agreement with patient reports, say researchers.
-
- Jun 25, 2010
- SRT a viable treatment option for recurrent localized prostate cancer Salvage radiotherapy following high-intensity focused ultrasound provides satisfactory rates of progression-free survival in patients with recurrent localized prostate cancer, suggest results published in the journal
Not signed in
Information
This is an AstraZeneca International website for healthcare professionals and is not intended for the following audiences who should use the links below.
Subscribe to RSS News Feed